Kenneth d’Entremont
Vermögen: 4 Mio $ am 31.05.2026
Vermögen: 4 Mio $ am 31.05.2026
Kenneth d’Entremont was the founder of Medexus, Inc., founded in 2000, where the titles held included President, Chief Executive Officer & Director from 2000 to 2018.
The current job is Chief Executive Officer & Director at Medexus Pharmaceuticals, Inc. starting in 2018.
Former job includes General Manager & VP-Business Development at Sanofi Canada, Inc. from 1984 to 1999.
Education includes undergraduate studies at McMaster University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.12.2025 | 1 504 807 ( 4,66 % ) | 4 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Vorstandsvorsitzender | 17.12.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
Medexus, Inc.
Medexus, Inc. Drugstore ChainsRetail Trade Engages in licensing, registration, marketing, sales and distribution of pharmaceutical products | Gründer | 17.12.2018 |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01.01.1999 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medexus Pharmaceuticals, Inc.
Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and distributes pharmaceutical products | Health Technology |
Medexus, Inc.
Medexus, Inc. Drugstore ChainsRetail Trade Engages in licensing, registration, marketing, sales and distribution of pharmaceutical products | Retail Trade |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen